Schonfeld Strategic Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$330K Buy
+78,861
New +$380K ﹤0.01% 1537
2023
Q4
Sell
-20,000
Closed -$51.8K 1879
2023
Q3
$51.8K Buy
20,000
+9,400
+89% +$33K ﹤0.01% 1534
2023
Q2
$41.8K Buy
+10,600
New +$33.6K ﹤0.01% 1833
2021
Q1
Sell
-12,500
Closed -$139K 1804
2020
Q4
$139K Sell
12,500
-7,600
-38% -$77.5K ﹤0.01% 1404
2020
Q3
$202K Buy
+20,100
New +$203K ﹤0.01% 1211

Other funds holding SRTA

Schonfeld Strategic Advisors's SRTA Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Strata Critical Medical Inc (SRTA) in Q1 2026: 78,861 shares worth $330K. The stake represents ﹤0.01% of the portfolio and ranks #1537 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in SRTA as recently as Q3 2023.

Schonfeld Strategic Advisors first reported a position in SRTA in Q3 2020 and has held it in 5 quarters since. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Schonfeld Strategic Advisors held 78,861 shares of Strata Critical Medical Inc worth $330K as of Q1 2026.
  • Strata Critical Medical Inc was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Strata Critical Medical Inc made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1537 holding.
  • Schonfeld Strategic Advisors first reported a position in Strata Critical Medical Inc in Q3 2020 and has held it in 5 quarters since.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.